对侧颈动脉闭塞对颈动脉内膜切除术后结局的影响
基于VSGNE登记2003–2015年15487例颈动脉内膜切除术患者,比较对侧颈动脉闭塞(CCO)及不同程度对侧颈动脉狭窄(CCS)的结局。校正后CCO与30天卒中/死亡、院内卒中及住院时间延长独立相关,但绝对风险仍在14学会指南推荐阈值内;80%–99% CCS仅与住院时间延长相关。CCO不应作为CEA的高危标准。
要点
- CCO增加CEA后30天卒中/死亡风险(OR 2.1),但绝对风险仍低于指南阈值。
- CCO与院内同侧及对侧卒中风险升高相关,对侧卒中OR达5.1。
- 80%–99%对侧颈动脉狭窄仅与住院时间延长相关,不增加院内卒中。
核心结论
- CCO增加CEA后30天卒中/死亡、院内卒中和住院时间延长风险,但风险仍在14学会指南推荐阈值内,CCO不应作为CEA高危标准。
研究设计与样本
- 回顾性队列研究,纳入Vascular Study Group of New England登记2003–2015年接受CEA的15487例患者,其中无症状10377例(67%),CCO 914例(75%无症状)。
主要发现
- 症状性患者30天卒中/死亡率为2.0%(CCO 2.6%),无症状患者为1.1%(CCO 2.3%)。
- 校正后CCO与30天卒中/死亡(OR 2.1;95%CI 1.4-3.3;P=.001)、院内卒中(OR 2.8;95%CI 1.7-4.6;P<.001)、院内同侧卒中(OR 2.2;95%CI 1.2-4.0;P=.02)、院内对侧卒中(OR 5.1;95%CI 2.2-11.4;P<.001)及住院时间延长(OR 1.6;95%CI 1.3-1.9;P<.001)相关。
- 80%–99% CCS仅与住院时间延长相关(OR 1.3;95%CI 1.1-1.6;P=.01),与院内卒中无关。
- CCO和CCS均与30天死亡率无关。
临床怎么用
- 对合并CCO的患者,CEA仍是有效且安全的选择,不应仅因CCO而改行颈动脉支架置入。
- CCO患者CEA后需关注卒中风险及住院时间延长,但绝对风险符合指南可接受范围。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Patients with contralateral carotid occlusion (CCO) have been excluded from randomized clinical trials because of a deemed high risk for adverse neurologic outcomes with carotid endarterectomy (CEA). Evidence for this rationale is limited and conflicting. Therefore, we aimed to compare outcomes after CEA between patients with and without CCO and varying degrees of contralateral carotid stenosis (CCS). METHODS: We identified patients undergoing CEA from 2003 to 2015 in the Vascular Study Group of New England (VSGNE) registry. Patients were stratified by preoperative symptom status and presence of CCO. Multivariable analysis was used to account for differences in demographics and comorbidities. Our primary outcome was 30-day stroke/death risk. RESULTS: Of 15,487 patients we identified who underwent CEA, 10,377 (67%) were asymptomatic. CCO was present in 914 patients, of whom 681 (75%) were asymptomatic. Overall, the 30-day stroke/death was 2.0% for symptomatic patients (CCO: 2.6%) and 1.1% for asymptomatic patients (CCO: 2.3%). After adjustment, including symptom status, CCO was associated with higher 30-day stroke/death (odds ratio [OR], 2.1; 95% confidence interval [CI], 1.4-3.3; P = .001), any in-hospital stroke (OR, 2.8; 95% CI, 1.7-4.6; P < .001), in-hospital ipsilateral stroke (OR, 2.2; 95% CI, 1.2-4.0; P = .02), in-hospital contralateral stroke (OR, 5.1; 95% CI, 2.2-11.4; P < .001), and prolonged length of stay (OR, 1.6; 95% CI, 1.3-1.9; P < .001). CCS of 80% to 99% was only associated with a prolonged length of stay (OR, 1.3; 95% CI, 1.1-1.6; P = .01), not with in-hospital stroke. Neither CCO nor CCS was associated with 30-day mortality. CONCLUSIONS: Although CCO increases the risk of 30-day stroke/death, in-hospital strokes, and prolonged length of stay after CEA, the 30-day stroke/death rates in symptomatic and asymptomatic patients with CCO remain within the recommended thresholds set by the 14 societies' guideline document. Thus, CCO should not qualify as a high-risk criterion for CEA. Moreover, there is no evidence that patients with CCO have lower stroke/death rates after carotid artery stenting than after CEA. We believe that CEA remains a valid and safe option for patients with CCO and that CCO should not be applied as a criterion to promote carotid artery stenting per se.
引用
- Pothof AB, Soden PA, Fokkema M, et al. The impact of contralateral carotid artery stenosis on outcomes after carotid endarterectomy. J Vasc Surg. 2017. PMID: 28655552. doi:10.1016/j.jvs.2017.04.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。